Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

101 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study.
Rizzardini G, Eskesen D, Calder PC, Capetti A, Jespersen L, Clerici M. Rizzardini G, et al. Among authors: capetti a. Br J Nutr. 2012 Mar;107(6):876-84. doi: 10.1017/S000711451100420X. Epub 2011 Sep 7. Br J Nutr. 2012. PMID: 21899798 Clinical Trial.
Four years of immunization with OM-85 BV to prevent respiratory infections in HIV+ patients.
Capetti A, Cossu MV, Carenzi L, Rizzardini G. Capetti A, et al. Hum Vaccin Immunother. 2013 Sep;9(9):1849-51. doi: 10.4161/hv.25104. Epub 2013 Jun 21. Hum Vaccin Immunother. 2013. PMID: 23792443 Free PMC article.
An immunological comparison of third companion in advanced drug-naive HIV-infected patients.
Rizzardini G, Trabattoni D, Capetti A, Castelletti E, Migliorino M, Panebianco R, Pacei M, Quirino T, Clerici M. Rizzardini G, et al. Among authors: capetti a. HIV Clin Trials. 2006 Sep-Oct;7(5):221-8. doi: 10.1310/hct0705-221. HIV Clin Trials. 2006. PMID: 17162315 Clinical Trial.
96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience.
Capetti A, Landonio S, Meraviglia P, Di Biagio A, Lo Caputo S, Sterrantino G, Ammassari A, Menzaghi B, Franzetti M, De Socio GV, Pellicanò G, Mazzotta E, Soria A, Meschiari M, Trezzi M, Sasset L, Celesia BM, Zucchi P, Melzi S, Ricci E, Rizzardini G. Capetti A, et al. PLoS One. 2012;7(7):e39222. doi: 10.1371/journal.pone.0039222. Epub 2012 Jul 11. PLoS One. 2012. PMID: 22808029 Free PMC article.
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study.
Capetti A, Meraviglia P, Landonio S, Sterrantino G, Di Biagio A, Lo Caputo S, Ammassari A, Menzaghi B, De Socio GV, Franzetti M, Soria A, Meschiari M, Sasset L, Pellicanò G, Mazzotta E, Trezzi M, Celesia BM, Melzi S, Carenzi L, Ricci E, Rizzardini G. Capetti A, et al. Int J Antimicrob Agents. 2014 Feb;43(2):189-94. doi: 10.1016/j.ijantimicag.2013.10.013. Epub 2013 Nov 15. Int J Antimicrob Agents. 2014. PMID: 24315315
Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders.
Piconi S, Parisotto S, Rizzardini G, Passerini S, Terzi R, Argenteri B, Meraviglia P, Capetti A, Biasin M, Trabattoni D, Clerici M. Piconi S, et al. Among authors: capetti a. Blood. 2011 Sep 22;118(12):3263-72. doi: 10.1182/blood-2011-01-329060. Epub 2011 May 16. Blood. 2011. PMID: 21576701
Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort.
Di Biagio A, Prinapori R, Giannarelli D, Maggiolo F, Di Giambenedetto S, Borghi V, Penco G, Cicconi P, Francisci D, Sterrantino G, Zoncada A, Monno L, Capetti A, Giacometti A; ARCA Collaborative Group. Di Biagio A, et al. Among authors: capetti a. J Antimicrob Chemother. 2013 Jan;68(1):200-5. doi: 10.1093/jac/dks339. Epub 2012 Aug 21. J Antimicrob Chemother. 2013. PMID: 22915463
Nanoformulation of antiretroviral drugs enhances their penetration across the blood brain barrier in mice.
Fiandra L, Colombo M, Mazzucchelli S, Truffi M, Santini B, Allevi R, Nebuloni M, Capetti A, Rizzardini G, Prosperi D, Corsi F. Fiandra L, et al. Among authors: capetti a. Nanomedicine. 2015 Aug;11(6):1387-97. doi: 10.1016/j.nano.2015.03.009. Epub 2015 Apr 1. Nanomedicine. 2015. PMID: 25839392
Strategic use of dual regimens of boosted protease inhibitors plus maraviroc in poorly adherent subjects in view of long-acting drugs: A retrospective study.
Capetti AF, Micale M, Carenzi L, Niero F, Landonio S, Vimercati S, Dedivitiis G, Rizzardini G. Capetti AF, et al. Medicine (Baltimore). 2017 Feb;96(7):e5728. doi: 10.1097/MD.0000000000005728. Medicine (Baltimore). 2017. PMID: 28207500 Free PMC article.
Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy.
Riva C, Lai A, Caramma I, Corvasce S, Violin M, Dehò L, Prati F, Rossi C, Colombo MC, Capetti A, Franzetti M, Rossini V, Tambussi G, Ciccozzi M, Suligoi B, Mussini C, Rezza G, Balotta C. Riva C, et al. Among authors: capetti a. AIDS Res Hum Retroviruses. 2010 Jan;26(1):41-9. doi: 10.1089/aid.2009.0057. AIDS Res Hum Retroviruses. 2010. PMID: 20055587
101 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback